According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.29 B. a decrease over its 2022 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.29 B | 87.79% |
2022 | -$0.16 B | -20.1% |
2021 | -$0.19 B | 67.59% |
2020 | -$0.12 B | -347.53% |
2019 | $45.39 M | -245.59% |
2018 | -$31.18 M | -13.17% |
2017 | -$35.91 M | -52.28% |
2016 | -$75.26 M | -16.57% |
2015 | -$90.2 M | 30.32% |
2014 | -$69.21 M | 171.62% |
2013 | -$25.49 M | 16.56% |
2012 | -$21.87 M | 107.53% |
2011 | -$10.54 M | |
2008 | -$37.11 M | -8.07% |
2007 | -$40.37 M | 70.37% |
2006 | -$23.69 M | 122.51% |
2005 | -$10.65 M | 147.41% |
2004 | -$4.31 M | 2002.28% |
2003 | -$0.21 M | -85.61% |
2002 | -$1.43 M | 1371.97% |
2001 | -$0.1 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -6,106.89% | ๐บ๐ธ USA |
Moderna
MRNA | -$3.91 B | 1,281.74% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | $64.31 M | -122.76% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | -$0.12 B | -58.36% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.32 B | 10.53% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | -$0.14 B | -52.61% | ๐บ๐ธ USA |